Case Study: CRISPR Screening

Admera Health In Vivo CRISPR Screen Knockout:
Decoding Mouse Ovarian Cancer Progression & Therapeutics

Introduction

Researchers employed an in vivo CRISPR knockout screen in a mouse model of ovarian cancer, leveraging a collaboration with Admera Health for their expertise in complex tissue genomics and bioinformatics, to identify critical genes driving cancer progression and uncover potential therapeutic targets.

Discover our Advanced Pipelines & Support

  • Admera Health’s CRISPR screening knockout service 

    • Experimental design and methodology

  • Admera Health’s impact on in vivo CRISPR screening success

Related Services

dna-seq services
single cell sequencing service
Admera Health offers exceptional RNA-seq services with flexibility and capability for high-throughput according to customers’ needs.